The rapid expansion of aquaculture has necessitated advancements in fish vaccination, reducing reliance on antibiotics and improving disease control. While injection-based vaccines provide effective immunization, they can cause adverse reactions such as inflammation and pigmentation. Minimizing these side effects has driven the development of micro-dose vaccines.
Socorex: A pioneer in precision dosing
A key player in this innovation is the Swiss company Socorex, a pioneer in precision liquid dosing. Initially focused on medical-grade syringes, Socorex expanded into the animal health sector in the 1980s. Leveraging its expertise in lab and biotech fields, the company introduced the ultra 1810 syringe, a breakthrough in aquaculture vaccination. The device enables accurate delivery of doses as low as 0.02 mL minimizing injection-related complications.
Precision and versatility in vaccine delivery
Socorex’s syringes have a 99-99.5% precision rate, a crucial factor in optimizing vaccine delivery efficacy and reducing costs. The ultra 1810 line accommodates dose volumes between 0.02 and 0.5 mL, and is suitable for multiple fish species, including salmonids, tilapia, and seabass. It works with both oil- and water-based vaccines and is highly durable, resistant to shocks and saltwater exposure. Additional accessories, such as the FishGuide™ for proper fish positioning and the Abacus™ counter for dose tracking, further enhance its functionality.
Conclusion
By refining vaccine administration, Socorex has significantly contributed to the sustainable growth of aquaculture. The company’s innovations help fish farmers reduce stress on fish, lower the costs, and improve productivity, reinforcing its role as a leader in micro-dose vaccine delivery.